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Background
The choroid plexus is a major site of gene expression of
esophageal cancer-related gene (ECRG)-4 during devel-
opment, suggesting that its gene product may be involved
in cerebrospinal fluid (CSF) homeostasis. Yet, ECRG-4 is
also a novel candidate tumor suppressor gene whose
expression is downregulated and is inversely associated
with a worse prognosis in several different cancers.
Reduced expression of ECRG-4 has been demonstrated
in most tumors, including colorectal carcinoma and
malignant glioma, to be mediated by hypermethylation of
its promoter.
Materials and methods
In this study, samples of normal human choroid plexus
(both fetal and adult) and choroid plexus neoplasms
(WHO grade I papilloma, grade II atypical papilloma,
and grade III carcinoma) were stained with antibodies
that we generated to augurin, the gene product of ECRG-
4. DNA was then extracted from the tissue, treated with
bisulfite, and subjected to PCR using a 217-base pair
region encompassing the ECRG-4 promotor to detect
methylation.
Results
Both fetal and adult human choroid plexus cells demon-
strated a robust positive immunostaining at the apical
surface that is consistent with our prior results in
human, rat, and mouse brains. In contrast, there was a
near-complete absence of immunostaining in all of the
choroid plexus neoplasms examined. The choroid plexus
carcinoma demonstrated significant methylation of the
ECRG-4 promotor region.
Conclusions
Taken together, these data suggest that ECRG-4 is down-
regulated in neoplasms of the choroid plexus just as has
been observed in other central nervous system (CNS) and
non-CNS cancers. This is likely due to hypermethylation
of the ECRG-4 promotor, as shown in the choroid plexus
carcinoma. Further analysis is underway to determine the
(1) physiologic and (2) pathophysiologic consequences of
ECRG-4 over- and under- expression in the choroid
plexus on CSF formation, function, and composition.
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